NO20034617L - Fremgangsmåter for å inhibere viral replikasjon - Google Patents

Fremgangsmåter for å inhibere viral replikasjon

Info

Publication number
NO20034617L
NO20034617L NO20034617A NO20034617A NO20034617L NO 20034617 L NO20034617 L NO 20034617L NO 20034617 A NO20034617 A NO 20034617A NO 20034617 A NO20034617 A NO 20034617A NO 20034617 L NO20034617 L NO 20034617L
Authority
NO
Norway
Prior art keywords
methods
viral replication
inhibit viral
inhibit
replication
Prior art date
Application number
NO20034617A
Other languages
English (en)
Other versions
NO20034617D0 (no
Inventor
Asim Dasgupta
Saumitra Das
Narayan Baidya
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NO20034617D0 publication Critical patent/NO20034617D0/no
Publication of NO20034617L publication Critical patent/NO20034617L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4705Regulators; Modulating activity stimulating, promoting or activating activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20034617A 2001-04-16 2003-10-15 Fremgangsmåter for å inhibere viral replikasjon NO20034617L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/836,073 US20020173475A1 (en) 2001-04-16 2001-04-16 Methods to inhibit viral replication
PCT/US2002/011589 WO2002083858A2 (en) 2001-04-16 2002-04-12 Methods to inhibit viral replication

Publications (2)

Publication Number Publication Date
NO20034617D0 NO20034617D0 (no) 2003-10-15
NO20034617L true NO20034617L (no) 2003-11-26

Family

ID=25271170

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034617A NO20034617L (no) 2001-04-16 2003-10-15 Fremgangsmåter for å inhibere viral replikasjon

Country Status (10)

Country Link
US (1) US20020173475A1 (no)
EP (1) EP1390392A4 (no)
JP (1) JP2004533823A (no)
KR (1) KR20040002917A (no)
CN (1) CN1636016A (no)
CA (1) CA2444047A1 (no)
IL (1) IL158411A0 (no)
NO (1) NO20034617L (no)
WO (1) WO2002083858A2 (no)
ZA (1) ZA200308824B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004058171A2 (en) 2002-12-20 2004-07-15 Protein Design Labs, Inc. Antibodies against gpr64 and uses thereof
JP2012513961A (ja) 2008-12-24 2012-06-21 シンジェンタ リミテッド 殺菌剤の調製方法
CA2870200A1 (en) * 2012-04-12 2013-10-17 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
KR101412077B1 (ko) * 2013-01-31 2014-06-26 전남대학교산학협력단 담배 모자이크 바이러스 방제용 펩타이드 및 그의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2201702A1 (en) * 1994-10-11 1996-04-18 Saumitra Das Selective inhibition of internally initiated rna translation
JP2002516100A (ja) * 1998-05-22 2002-06-04 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 酵母小rnaによるウイルスires媒介性翻訳への干渉は、重要なrna−タンパク質相互作用を明らかにする

Also Published As

Publication number Publication date
WO2002083858A2 (en) 2002-10-24
WO2002083858A8 (en) 2003-09-04
ZA200308824B (en) 2005-02-14
JP2004533823A (ja) 2004-11-11
IL158411A0 (en) 2004-05-12
EP1390392A1 (en) 2004-02-25
KR20040002917A (ko) 2004-01-07
US20020173475A1 (en) 2002-11-21
CN1636016A (zh) 2005-07-06
EP1390392A4 (en) 2005-03-02
NO20034617D0 (no) 2003-10-15
CA2444047A1 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
EE200300102A (et) Herpesviiruse sümptomite taastumise edasi lükkamise meetodid
DK1476185T3 (da) Antistoffer mod CD40
IS7243A (is) C-5 breytt indazólýlpýrrólótríazín
NO20032585D0 (no) ABCA-1 forhöyende forbindelser
DE60106823D1 (de) Motorrad
IS7851A (is) 1-asýl-pýrrólídínafleiður til að meðhöndla veirusýkingar
DE60113886D1 (de) Gestapelte Werkzeuge zum Überkopfkehren
DE60108453D1 (de) Motorrad
DE60219557D1 (de) Rollerartiges Motorrad
DE60124622T8 (de) Rollerartiges Motorrad
DK1434507T3 (da) Forbedringer til seng-og-bord-kombinationsmöbel
DK1389116T3 (da) Kathartisk præparat
HK1065734A1 (en) Tetrahydroindolone derivatives linked to arylpiperazines
IS6716A (is) Aðferðir við að framleiða sílostasól
NO20034617L (no) Fremgangsmåter for å inhibere viral replikasjon
ITUD20000151A1 (it) Centratore per levetappi
DE60143209D1 (de) Zweiport-demodulationseinrichtung
DE50307407D1 (de) Strömungsbremse
NO20023712L (no) Kokeprosess
DE50012174D1 (de) Winkelschleifer
ITRN20000032A0 (it) Monopattino
ITTO20020516A1 (it) Motociclo
NO20025628D0 (no) Overlevelseshjelp
ITTO20020523A1 (it) Motociclo
DE50015362D1 (de) Winkelschleifer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application